Gwinntanamo t1_jaq79an wrote
Reply to comment by BellaBlue06 in The Vyvanse patent expires this year. How long does it usually take generic alternatives to get approved, and how much of a reduction in cost is expected on average? by paleselan1
That’s not how it works. The 6-month extension is granted if the company conducts a study in pediatrics at any point in time. I haven’t looked, but I assume Vyvanse is actually indicated for some pediatric patients already (most ADHD drugs are). The extension is simply an incentive young kids - a patient segment that is often under studied with new products.
Viewing a single comment thread. View all comments